| __timestamp | ACADIA Pharmaceuticals Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 205018000 |
| Thursday, January 1, 2015 | 76369000 | 392709000 |
| Friday, January 1, 2016 | 4406000 | 299694000 |
| Sunday, January 1, 2017 | 13060000 | 397061000 |
| Monday, January 1, 2018 | 18330000 | 434100000 |
| Tuesday, January 1, 2019 | 19598000 | 782200000 |
| Wednesday, January 1, 2020 | 20550000 | 1119900000 |
| Friday, January 1, 2021 | 19141000 | 2437500000 |
| Saturday, January 1, 2022 | 10166000 | 1560400000 |
| Sunday, January 1, 2023 | 45731000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
In pursuit of knowledge
In the competitive landscape of biopharmaceuticals, understanding cost dynamics is crucial. Over the past decade, Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc. have shown contrasting trends in their cost of revenue. Regeneron, a leader in innovative medicines, has seen its cost of revenue skyrocket by over 780% from 2014 to 2023, reflecting its aggressive expansion and increased production. In contrast, ACADIA, known for its focus on central nervous system disorders, experienced a more volatile trend, with costs peaking in 2015 and then fluctuating, ending with a 24% increase in 2023 compared to 2014. This divergence highlights the different strategic paths these companies have taken, with Regeneron scaling up operations significantly, while ACADIA navigates a more variable cost structure. These insights provide a window into the operational strategies of these pharmaceutical powerhouses.
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc.
Cost of Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Lantheus Holdings, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Perrigo Company plc's Expenses
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.'s Expenses
Regeneron Pharmaceuticals, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
BeiGene, Ltd. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Intra-Cellular Therapies, Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Pharming Group N.V. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Cytokinetics, Incorporated vs ACADIA Pharmaceuticals Inc.
Analyzing Cost of Revenue: Alkermes plc and ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Efficiency in Cost of Revenue Explored